• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BDCA3(+)CLEC9A(+) 人类树突状细胞的功能和发育。

BDCA3(+)CLEC9A(+) human dendritic cell function and development.

机构信息

Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.

Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.

出版信息

Semin Cell Dev Biol. 2015 May;41:39-48. doi: 10.1016/j.semcdb.2014.05.016. Epub 2014 Jun 6.

DOI:10.1016/j.semcdb.2014.05.016
PMID:24910448
Abstract

Dendritic cells (DC) are the most potent antigen presenting cells (APC). They comprise a family of different subsets and play an essential role in the induction and regulation of immune responses. Recently, gene expression profiling identified BDCA3(+)CLEC9A(+) DC as a separate human DC subset. This subset was identified in blood, where they represent the smallest population of human DC, as well as in lymphoid and peripheral tissues. This review summarizes the phenotypic, functional and developmental characteristics of BDCA3(+)CLEC9A(+) DC in relation to their mouse equivalents CD8α(+) DC and CD103(+) DC and other human DC subsets. Apart from being potent antigen presenting cells, their specialized functional capacities compared to other human DC subsets, indicate that these BDCA3(+)CLEC9A(+) DC are of major importance in the induction of anti-viral and anti-tumor immunity. Further characterization of their functional properties, developmental pathways and underlying molecular mechanisms may identify target molecules to fully exploit the immune modulatory function of BDCA3(+)CLEC9A(+) DC and potential use of these cells in immunotherapy.

摘要

树突状细胞(DC)是最有效的抗原提呈细胞(APC)。它们由不同亚群组成,在诱导和调节免疫反应中发挥着重要作用。最近,基因表达谱分析鉴定出 BDCA3(+)CLEC9A(+)DC 是一种独立的人类 DC 亚群。该亚群在血液中被发现,在血液中它们代表人类 DC 中最小的群体,也存在于淋巴样和外周组织中。这篇综述总结了 BDCA3(+)CLEC9A(+)DC 的表型、功能和发育特征,与它们的小鼠对应物 CD8α(+)DC 和 CD103(+)DC 以及其他人类 DC 亚群进行了比较。除了作为有效的抗原提呈细胞外,与其他人类 DC 亚群相比,它们的特殊功能能力表明,这些 BDCA3(+)CLEC9A(+)DC 在诱导抗病毒和抗肿瘤免疫方面具有重要意义。进一步表征其功能特性、发育途径和潜在的分子机制,可能确定目标分子,以充分利用 BDCA3(+)CLEC9A(+)DC 的免疫调节功能,并潜在地将这些细胞用于免疫治疗。

相似文献

1
BDCA3(+)CLEC9A(+) human dendritic cell function and development.BDCA3(+)CLEC9A(+) 人类树突状细胞的功能和发育。
Semin Cell Dev Biol. 2015 May;41:39-48. doi: 10.1016/j.semcdb.2014.05.016. Epub 2014 Jun 6.
2
The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells.C 型凝集素受体 CLEC9A 介导人血液 BDCA3+ 髓系树突状细胞对抗原的摄取和(交叉)呈递。
Blood. 2012 Mar 8;119(10):2284-92. doi: 10.1182/blood-2011-08-373944. Epub 2012 Jan 10.
3
BDCA3 expression is associated with high IFN-λ production by CD34(+)-derived dendritic cells generated in the presence of GM-CSF, IL-4, and/or TGF-β.BDCA3的表达与在GM-CSF、IL-4和/或TGF-β存在的情况下由CD34(+)衍生的树突状细胞产生的高干扰素-λ水平相关。
Eur J Immunol. 2015 May;45(5):1471-81. doi: 10.1002/eji.201444802. Epub 2015 Feb 14.
4
Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells.鉴定人 DNGR-1+BDCA3+ 白细胞为鼠 CD8alpha+ 树突状细胞的假定同系物。
J Exp Med. 2010 Jun 7;207(6):1261-71. doi: 10.1084/jem.20092618. Epub 2010 May 17.
5
Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation.抗原递送至早期内体消除了人血 BDCA3+树突状细胞在交叉呈递中的优势。
J Exp Med. 2013 May 6;210(5):1049-63. doi: 10.1084/jem.20121251. Epub 2013 Apr 8.
6
In Vitro Generation of Human XCR1(+) Dendritic Cells from CD34(+) Hematopoietic Progenitors.从CD34(+)造血祖细胞体外生成人XCR1(+)树突状细胞。
Methods Mol Biol. 2016;1423:19-37. doi: 10.1007/978-1-4939-3606-9_2.
7
The Superior Ability of Human BDCA3 (CD141) Dendritic Cells (DCs) to Cross-Present Antigens Derived From Necrotic Lung Cancer Cells.人类 BDCA3(CD141)树突状细胞(DCs)对源自坏死肺癌细胞的抗原具有优越的交叉呈递能力。
Front Immunol. 2020 Jun 19;11:1267. doi: 10.3389/fimmu.2020.01267. eCollection 2020.
8
Antibody-mediated targeting of antigen to C-type lectin-like receptors Clec9A and Clec12A elicits different vaccination outcomes.抗体介导的抗原靶向C型凝集素样受体Clec9A和Clec12A会引发不同的疫苗接种结果。
Mol Immunol. 2017 Jan;81:143-150. doi: 10.1016/j.molimm.2016.12.010. Epub 2016 Dec 12.
9
Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141 dendritic cells to activate naïve and memory NY-ESO-1-specific CD8 T cells.人 CLEC9A 抗体将 NY-ESO-1 抗原递呈给 CD141 树突状细胞,从而激活幼稚和记忆 NY-ESO-1 特异性 CD8 T 细胞。
J Immunother Cancer. 2020 Jul;8(2). doi: 10.1136/jitc-2020-000691.
10
Dendritic cell-associated lectin 2 (DCAL2) defines a distinct CD8α- dendritic cell subset.树突细胞相关凝集素 2(DCAL2)定义了一个独特的 CD8α-树突状细胞亚群。
J Leukoc Biol. 2012 Mar;91(3):437-48. doi: 10.1189/jlb.0711384. Epub 2011 Dec 6.

引用本文的文献

1
The Emerging Mechanisms and Therapeutic Potentials of Dendritic Cells in NSCLC.非小细胞肺癌中树突状细胞的新兴机制及治疗潜力
J Inflamm Res. 2025 Apr 14;18:5061-5076. doi: 10.2147/JIR.S506644. eCollection 2025.
2
Single-cell analysis uncovers liver susceptibility to pancreatic cancer metastasis via myeloid cell characterization.单细胞分析通过髓样细胞表征揭示肝脏对胰腺癌转移的易感性。
Discov Oncol. 2024 Nov 22;15(1):696. doi: 10.1007/s12672-024-01566-0.
3
Targeting aryl hydrocarbon receptor functionally restores tolerogenic dendritic cells derived from patients with multiple sclerosis.
靶向芳香烃受体功能恢复多发性硬化症患者来源的耐受性树突状细胞。
J Clin Invest. 2024 Nov 1;134(21):e178949. doi: 10.1172/JCI178949.
4
CD74 facilitates immunotherapy response by shaping the tumor microenvironment of hepatocellular carcinoma.CD74通过塑造肝细胞癌的肿瘤微环境促进免疫治疗反应。
Mol Med. 2024 Aug 8;30(1):116. doi: 10.1186/s10020-024-00884-x.
5
Endothelial biomarkers (Von willebrand factor, BDCA3, urokinase) as predictors of mortality in COVID-19 patients: cohort study.内皮生物标志物(血管性血友病因子、BDCA3、尿激酶)作为 COVID-19 患者死亡率的预测因子:队列研究。
BMC Pulm Med. 2024 Jul 4;24(1):325. doi: 10.1186/s12890-024-03136-0.
6
Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation.黑色素瘤中的树突状细胞亚群:病理生理学、临床预后及治疗应用
Cancers (Basel). 2023 Apr 8;15(8):2206. doi: 10.3390/cancers15082206.
7
The melanoma tumor glyco-code impacts human dendritic cells' functionality and dictates clinical outcomes.黑色素瘤肿瘤糖码影响人类树突状细胞的功能,并决定临床结果。
Front Immunol. 2023 Feb 20;14:1120434. doi: 10.3389/fimmu.2023.1120434. eCollection 2023.
8
Conventional dendritic cells type 1 are strongly enriched, quiescent and relatively tolerogenic in local inflammatory arthritis.在局部炎症性关节炎中,传统树突状细胞 1 型大量富集,处于静止状态,相对耐受。
Front Immunol. 2023 Jan 4;13:1101999. doi: 10.3389/fimmu.2022.1101999. eCollection 2022.
9
Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients.循环和肿瘤浸润 DC 亚群上独特的 CLR 表达模式与黑色素瘤患者的临床结局相关。
Front Immunol. 2022 Oct 24;13:1040600. doi: 10.3389/fimmu.2022.1040600. eCollection 2022.
10
Human lung cDC1 drive increased perforin-mediated NK cytotoxicity in chronic obstructive pulmonary disease.人肺 cDC1 驱动慢性阻塞性肺疾病中穿孔素介导的 NK 细胞毒性增加。
Am J Physiol Lung Cell Mol Physiol. 2021 Dec 1;321(6):L1183-L1193. doi: 10.1152/ajplung.00322.2020. Epub 2021 Oct 27.